BIM
CALA

Bogle Investment Management’s Calithera Biosciences, Inc CALA Stock Holding History

Bogle Investment Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,700
Closed -$535K – 379
2017
Q3 		$535K Sell
1,700
-23,185
-93% -$7.31M 0.04% 254
2017
Q2 		$7.39M Buy
24,885
+68
+0.3% +$18.2K 0.54% 79
2017
Q1 		$5.73M Buy
+24,817
New +$4.29M 0.4% 92

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.37% 1-Year Est. Return

Bogle Investment Management's CALA Position: Q4 2017 in Review

Bogle Investment Management sold out of Calithera Biosciences, Inc (CALA) in Q4 2017, closing a stake of 1,700 shares — an estimated $535K sold.

Bogle Investment Management first reported a position in CALA in Q1 2017 and held it in 3 quarters. The position peaked at $7.39M in Q2 2017. 112 funds tracked by Wall St. Rank hold CALA as of Q4 2017.

  • Bogle Investment Management reported no remaining Calithera Biosciences, Inc position as of Q4 2017 after selling out during the quarter.
  • Bogle Investment Management sold 1,700 Calithera Biosciences, Inc shares in Q4 2017, an estimated $535K.
  • Bogle Investment Management first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 3 quarters.
  • Bogle Investment Management's Calithera Biosciences, Inc position peaked at $7.39M in Q2 2017.
  • 112 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2017.

Based on Bogle Investment Management's 13F filing for Q4 2017, filed 13 Feb 2018.